Țuca Zbârcea & Asociații | NEWS & EVENTS
16 October 2015

Țuca Zbârcea & Asociații takes lead role as Interbrands Marketing & Distribution signs deal with GlaxoSmithKline

Țuca Zbârcea & Asociații advised on one of the most important deals taking place in the pharma sector since the beginning of the year. The firm acted for Interbrands Marketing & Distribution, the largest Romanian company in the distribution and marketing of fast moving consumer goods (FMCG), on its acquisition of Europharm Holding, a local drug distribution company owned by UK drugmaker GlaxoSmithKline. The disposal includes Europharm shares, as well as several additional commercial contracts.

With the signing of the deal on October 13th, a first stage of a lengthy and complicated process had been completed. All the more important, the firm’s lawyers were asked to play a crucial and intensive part in the final round of negotiations to facilitate consensus. The transaction is subject to antitrust clearance from Romania’s Competition Council and is conditioned by the completion of certain commercial terms.

Țuca Zbârcea & Asociații has advised the purchaser with a team in Bucharest also comprising Andreea Oprișan (Senior Associate).

„The team at Țuca Zbârcea provided Interbrands with professional, sustained and dedicated support during a complex transaction that lasted for over one year to our entire satisfaction. It is not the first time that we worked with this young, fun and dynamic team and in the future we would not hesitate retaining them again”, says Rand Sherif, CEO Interbrands.

Țuca Zbârcea & Asociații advised throughout the acquisition process, starting with the due diligence phase up to negotiation of transaction documents. The team will continue to act for Interbrands Marketing & Distribution as regards regulatory/competition clearance and the next steps in completing the closing.

Acest site folosește cookie-uri. Află in sectiunea Politica de Cookies mai multe despre cookie-uri.